UCLA Hematology/Oncology - Laguna Hills

Clinical research site in Laguna Hills, California

Part of UCLA

As of July 2026, 1 paid clinical trial is recruiting at UCLA Hematology/Oncology - Laguna Hills in Laguna Hills, California. Active studies at this site cover conditions such as Cancer of the Prostate, Hormone Sensitive Prostate Cancer and Metastatic Castration Sensitive Prostate Cancer (mCSPC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at UCLA Hematology/Oncology - Laguna Hills (1)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Explore more

Paid clinical trials in Laguna Hills, CA · California clinical trials

UCLA Hematology/Oncology - Laguna Hills

Recruiting clinical trials at UCLA Hematology/Oncology - Laguna Hills (1)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

More research sites in Laguna Hills

Explore more